An observational study in psychiatric acute patients admitted to General Hospital Psychiatric Wards in Italy

被引：15

作者：

Ballerini A. ^{[1
]}

Boccalon R. ^{[2
]}

Boncompagni G. ^{[3
]}

Casacchia M. ^{[4
]}

Margari F. ^{[5
]}

Minervini L. ^{[6
]}

Righi R. ^{[7
]}

Russo F. ^{[8
]}

Salteri A. ^{[9
]}

机构：

[1] S. Maria Nuova Hospital, Florence

[2] Sant' Anna Hospital, Ferrara

[3] S. Orsola Malpighi Hospital, Bologna

[4] San Salvatore Hospital, L'Aquila

[5] Policlinico Consorziale Hospital, Bari

[6] Azienda USL 16 Hospital, Padua

[7] Hospital of Adria, Rovigo

[8] Nuovo Regina Margherita Hospital, Rome

[9] Vimercate Civil Hospital, Milan

来源：

Annals of General Psychiatry | / 6卷 / 1期

关键词：

Schizophrenia; Personality Disorder; Acute Episode; Antisocial Personality Disorder; Brief Psychiatric Rate Scale;

D O I：

10.1186/1744-859X-6-2

中图分类号：

学科分类号：

摘要：

Objectives: This Italian observational study was aimed at collecting data of psychiatric patients with acute episodes entering General Hospital Psychiatric Wards (GHPWs). Information was focused on diagnosis (DSM-IV), reasons of hospitalisation, prescribed treatment, outcome of aggressive episodes, evolution of the acute episode. Methods: assessments were performed at admission and discharge. Used psychometric scales were the Brief Psychiatric Rating Scale (BPRS), the Modified Overt Aggression Scale (MOAS) and the Nurses' Observation Scale for Inpatient Evaluation (NOSIE-30). Results: 864 adult patients weree nrolled in 15 GHPWs: 728 (320 M; mean age 43.6 yrs) completed both admission and discharge visits. A severe psychotic episode with (19.1%) or without (47.7%) aggressive behaviour was the main reason of admission. Schizophrenia (42.8% at admission and 40.1% at discharge) and depression (12.9% at admission and 14.7% at discharge) were the predominant diagnoses. The mean hospital stay was 12 days. The mean (± SD) total score of MOAS at admission, day 7 and discharge was, respectively, 2.53 ± 5.1, 0.38 ± 2.2, and 0.21 ± 1.5. Forty-four (6.0%) patients had episodes of aggressiveness at admission and 8 (1.7%) at day 7. A progressive improvement in each domain/item vs. admission was observed for MOAS and BPRS, while NOSIE-30 did not change from day 4 onwards. The number of patients with al least one psychotic drug taken at admission, in the first 7 days of hospitalisation, and prescribed at discharge, was, respectively: 472 (64.8%), 686 (94.2%) and 676 (92.9%). The respective most frequently psychotic drugs were: BDZs (60.6%, 85.7%, 69.5%), typical anti-psychotics (48.3%, 57.0%, 49.6%), atypical anti-psychotics (35.6%, 41.8%, 39.8%) and antidepressants (40.9%, 48.8%, 43.2%). Rates of patients with one, two or > 2 psychotic drugs taken at admission and day 7, and prescribed at discharge, were, respectively: 24.8%, 8.2% and 13.5% in mono-therapy; 22.0%, 20.6% and 26.6% with two drugs, and 53.2%, 57.8% and 59.0% with > two drugs. Benzodiazepines were the most common drugs both at admission (60.0%) and during hospitalisation (85.7%), and 69.5% were prescribed at discharge. Conclusion: patients with psychiatric diseases in acute phase experienced a satisfactory outcome following intensified therapeutic interventions during hospitalisation. © 2007 Ballerini et al; licensee BioMed Central Ltd.

引用

共 19 条

[11] Kay S.R., Wolkenfeld F., Murrill L.M., Profiles of aggression among psychiatric patients. Nature and prevalence, J Nerv Ment Dis, 176, 9, pp. 539-546, (1988)
[12] Honingfeld G., NOSIE: Nurses' Observation Scale for Inpatient Evaluation, ECDEU Assessment Manual for Psychopharmacology, (1976)
[13] Sechter D., Caillard V., Cuche H., Deniker P., Open clinical study of cis(Z)-clopenthixol, Acta Psychiatr Scand Suppl, 294, pp. 20-24, (1981)
[14] Poluzzi E., Motola D., Silvani C., Desur Ponti F., Vaccheri A., Montanaro N., Prescriptions of antidepressants in primary care in Italy: Pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement, Eur J Clin Pharmacol, 59, 11, pp. 825-831, (2004)
[15] Tarricone R., Fattore G., Gerzeli S., Serra G., Taddei C., Percudani M., The costs of pharmacological treatment for major depression. The Italian Prospective Multicentre Observational Incidence-Based Study, Pharmacoeconomics, 17, 2, pp. 167-174, (2000)
[16] Magliano L., Fiorillo A., Guarneri M., Marasco C., DesurRosa C., Malangone C., Maj M., Prescription of psychotropic drugs to patients with schizophrenia: An Italian national survey, Eur J Clin Pharmacol, (2004)
[17] Barbui C., Campomori A., D'Avanzo B., Negri E., Garattini S., Antidepressant drug use in Italy since the introduction of SSRIs: National trends, regional differences and impact on suicide rates, Soc Psychiatry Psychiatr Epidemiol, 34, 3, pp. 152-156, (1999)
[18] Paton C., Lelliott P., Harrington M., Okocha C., Sensky T., Duffett R., Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients, J Psychopharmacol, 17, 2, pp. 223-229, (2003)
[19] Centorrino F., Eakin M., Bahk W.M., Kelleher J.P., Goren J., Salvatore P., Egli S., Baldessarini R.J., Inpatient antipsychotic drug use in 1998, 1993, and 1989, Am J Psychiatry, 159, 11, pp. 1932-1935, (2002)

← 1 2 →